| 1BIX |
2.2 |
THE CRYSTAL STRUCTURE OF THE HUMAN DNA REPAIR ENDONUCLEASE HAP1 SUGGESTS THE RECOGNITION OF EXTRA-HELICAL DEOXYRIBOSE AT DNA ABASIC SITES |
| 1CQG |
|
HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN HUMAN THIOREDOXIN (C35A, C62A, C69A, C73A) MUTANT AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN REF-1 (RESIDUES 59-71 OF THE P50 SUBUNIT OF NFKB), NMR, 31 STRUCTURES |
| 1CQH |
|
HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN HUMAN THIOREDOXIN (C35A, C62A, C69A, C73A) MUTANT AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN REF-1 (RESIDUES 59-71 OF THE P50 SUBUNIT OF NFKB), NMR, MINIMIZED AVERAGE STRUCTURE |
| 1DE8 |
2.95 |
HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE-1 (APE1) BOUND TO ABASIC DNA |
| 1DE9 |
3.0 |
HUMAN APE1 ENDONUCLEASE WITH BOUND ABASIC DNA AND MN2+ ION |
| 1DEW |
2.65 |
CRYSTAL STRUCTURE OF HUMAN APE1 BOUND TO ABASIC DNA |
| 1E9N |
2.2 |
A second divalent metal ion in the active site of a new crystal form of human apurinic/apyrimidinic endonuclease, Ape1, and its implications for the catalytic mechanism |
| 1HD7 |
1.95 |
A Second Divalent Metal Ion in the Active Site of a New Crystal Form of Human Apurinic/Apyridinimic Endonuclease, Ape1, and its Implications for the Catalytic Mechanism |
| 2ISI |
2.76 |
Crystal structure of Ape1 from Homo sapiens in a new crystal form complexed with a ligand |
| 2O3H |
1.9 |
Crystal structure of the human C65A Ape |
| 3U8U |
2.15 |
Crystal structure of Human Apurinic/Apyridinimic Endonuclease, Ape1 in a new crystal form |
| 4IEM |
2.3936 |
Human apurinic/apyrimidinic endonuclease (APE1) with product DNA and Mg2+ |
| 4LND |
1.92 |
Crystal structure of human apurinic/apyrimidinic endonuclease 1 with essential Mg2+ cofactor |
| 4QH9 |
2.175 |
Crystal structure of Mn2+ bound human APE1 |
| 4QHD |
1.65 |
Crystal structure of apo human APE1 |
| 4QHE |
1.4 |
Crystal structure of Mg2+ bound human APE1 |
| 5CFG |
1.8 |
C2 crystal form of APE1 with Mg2+ |
| 5DFF |
1.57 |
Human APE1 product complex |
| 5DFH |
1.949 |
Human APE1 mismatch product complex |
| 5DFI |
1.63 |
Human APE1 phosphorothioate substrate complex |
| 5DFJ |
1.85 |
Human APE1 E96Q/D210N mismatch substrate complex |
| 5DG0 |
1.8 |
Human APE1 phosphorothioate substrate complex with Mn2+ |
| 5WN0 |
2.6 |
APE1 exonuclease substrate complex with a C/G match |
| 5WN1 |
2.3 |
APE1 exonuclease product complex |
| 5WN2 |
2.288 |
APE1 exonuclease substrate complex with phosphoglycolate |
| 5WN3 |
2.0 |
APE1 F266A exonuclease substrate complex with a C/T mismatch |
| 5WN4 |
2.1 |
APE1 exonuclease substrate complex with a C/T mismatch |
| 5WN5 |
2.2 |
APE1 exonuclease substrate complex with a C/T mismatch and Mn2+ |
| 6BOQ |
1.96 |
Human APE1 substrate complex with an A/A mismatch adjacent the THF |
| 6BOR |
1.84 |
Human APE1 substrate complex with an G/G mismatch adjacent the THF |
| 6BOS |
2.304 |
Human APE1 substrate complex with an A/C mismatch adjacent the THF |
| 6BOT |
2.3 |
Human APE1 substrate complex with an C/C mismatch adjacent the THF |
| 6BOU |
2.538 |
Human APE1 substrate complex with an T/C mismatch adjacent the THF |
| 6BOV |
1.975 |
Human APE1 substrate complex with an A/G mismatch adjacent the THF |
| 6BOW |
1.59 |
Human APE1 substrate complex with an T/T mismatch adjacent the THF |
| 6MK3 |
1.478 |
Crystallographic solvent mapping analysis of DMSO bound to APE1 |
| 6MKK |
1.442 |
Crystallographic solvent mapping analysis of DMSO/Mg bound to APE1 |
| 6MKM |
1.673 |
Crystallographic solvent mapping analysis of DMSO/Tris bound to APE1 |
| 6MKO |
2.09 |
Crystallographic solvent mapping analysis of glycerol bound to APE1 |
| 6P93 |
2.1 |
Human APE1 K98A AP-endonuclease product complex |
| 6P94 |
2.09 |
Human APE1 C65A AP-endonuclease product complex |
| 6W0Q |
1.89 |
APE1 endonuclease product complex D148E |
| 6W2P |
1.94 |
APE1 endonuclease product complex L104R |
| 6W3L |
2.59 |
APE1 exonuclease substrate complex wild-type |
| 6W3N |
2.69 |
APE1 exonuclease substrate complex D148E |
| 6W3Q |
2.49 |
APE1 exonuclease substrate complex L104R |
| 6W3U |
2.4 |
APE1 exonuclease substrate complex R237C |
| 6W43 |
1.99 |
APE1 AP-endonuclease product complex R237C |
| 6W4I |
2.2 |
APE1 Y269A product complex with abasic DNA |
| 6W4T |
2.77 |
APE1 Y269A phosphorothioate substrate complex with abasic DNA |
| 7LPG |
2.08 |
APE1 product complex with abasic ribonucleotide DNA |
| 7LPH |
1.99 |
APE1 Mn-bound product complex with abasic ribonucleotide DNA |
| 7LPI |
2.05 |
APE1 phosphorothioate substrate complex with abasic ribonucleotide DNA |
| 7LPJ |
2.56 |
APE1 Mn-bound phosphorothioate substrate complex with abasic ribonucleotide DNA |
| 7MCR |
1.9 |
Human Apex/Ref1 homodimer formed under oxidative condition |
| 7MEV |
1.6 |
Human Apex/Ref1 monomer with C138A mutation |
| 7SUV |
1.99 |
APE1 exonuclease substrate complex with 8oxoG opposite A |
| 7SVB |
2.24 |
APE1 exonuclease substrate complex with 8oxoG opposite C |
| 7TC2 |
1.43 |
Human APE1 in complex with 5-nitroindole-2-carboxylic acid |
| 7TC3 |
1.252 |
Human APE1 in the apo form |
| 7U50 |
3.4 |
APE1 bound to a nucleosome core particle with AP-site at SHL-6 |
